Obesity is a leading cause of death in millions of people each year. The obesity epidemic only continues to grow as many of us continue to live unhealthy lifestyles with our unhealthy diet and lack of regular exercise.
Costa Mesa, Ca (PRWEB) March 25, 2013
Contract Research Organization, WCCT Global, today announced they are implementing a strong focus on clinical research for obesity treatments. The World Health Organization has alerted the public and medical community that obesity has been on the rise for the last 20 years and continues to grow. With this epidemic continually mounting, WCCT Global is focusing resources on early phase research to treat individuals suffering from obesity. They have done this by establishing a database of over 7,000 people who are stratified by BMI and can be categorized as either overweight or obese. These individuals have expressed the desire to participate in clinical research in obesity. There are four areas of research that would coincide with the characteristics of the WCCT Database: weight loss (appetite suppressant), type 2 diabetes, hypertension and cholesterol / triglyceride control. The demand for safe and reliable treatments for these obesity-associated morbidities is growing at a rapid rate. WCCT Global has conducted multiple clinical studies in all three of these areas. Dr. Mel Affrime, Sr.VP, Translational Medicine for WCCT Global states, “Obesity is a leading cause of death in millions of people each year. The obesity epidemic only continues to grow as many of us continue to live unhealthy lifestyles with our unhealthy diet and lack of regular exercise. Therefore, WCCT Global looks forward to participating in the public health efforts in obesity to hopefully begin to control of this problem within the next decade.”
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you would like to request information about how WCCT Global can assist your organization with a clinical study, please CLICK HERE.